MALIGNANT PARAGANGLIOMA
Clinical trials for MALIGNANT PARAGANGLIOMA explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT PARAGANGLIOMA trials appear
Sign up with your email to follow new studies for MALIGNANT PARAGANGLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radioactive therapy takes aim at resistant childhood cancer
Disease control Recruiting nowThis study tests a radioactive drug called I-MIBG in people with resistant neuroblastoma or related tumors (pheochromocytoma and paraganglioma). The drug is designed to deliver radiation directly to cancer cells. Researchers want to see if it can shrink tumors and how safe it is.…
Matched conditions: MALIGNANT PARAGANGLIOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can molecular markers revolutionize adrenal cancer management?
Knowledge-focused Recruiting nowThis study aims to bring molecular markers into routine care for patients with rare adrenal cancers. Researchers will collect blood, urine, and tumor samples from 450 patients before and after surgery to see if these markers can guide treatment decisions. The goal is to make thes…
Matched conditions: MALIGNANT PARAGANGLIOMA
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC